Global Dermatologicals Market Overview, Size, Share and Trends 2021
Dermatologicals is expected to be largely unaffected by COVID-19, with similar healthy double-digit value growth as 2019. However, part of this growth in 2020 is driven by inflation as a result of the economic effect of COVID-19, which has led to some price rises. However, there is expected to be a slight change in purchasing behaviour. As in 2019, medicated shampoo is expected to register the highest current value growth in 2020. However, other products areas are also expected to perform well b...
ALSO READ : http://www.marketwatch.com/story/global-voglibose-market-research-report-2021-2021-03-13
Euromonitor International's Dermatologicals in Nigeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table ofContent
KEY DATA FINDINGS
2020 IMPACT
Dermatologicals largely unaffected by COVID-19
Neimeth International Pharmaceuticals leads
dermatologicals in 2020
Chemists/pharmacies remains the leading
distribution channel for dermatologicals
RECOVERY AND OPPORTUNITIES
Healthy value growth expected during forecast
period, though more expensive product areas could register decline if economy
severely hit
Demand for nappy (diaper) rash treatments
supported by high birth rate
Antifungals registers strong performance over
the forecast period
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category:
Value 2015-2020
Table 2 Sales of Dermatologicals by Category: %
Value Growth 2015-2020
Table 3 NBO Company Shares of Dermatologicals:
% Value 2016-2020
Table 4 LBN Brand Shares of Dermatologicals: %
Value 2017-2020
Table 5 Forecast Sales of Dermatologicals by
Category: Value 2020-2025
Table 6 Forecast Sales of Dermatologicals by
Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods
and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
…... continued
CONTACT
DETAILS :
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment